Industry Symposium by Bayer

IND 22 - Latest Innovations and a Glimpse into the Future of Contrast-Enhanced MRI

  • ECR 2025
  • 5 Lectures
  • 60 Minutes
  • 4 Speakers

Log in to watch for free!

Lectures

1
Latest Innovations and a Glimpse into the Future of Contrast-Enhanced MRI (Complete Session)

Latest Innovations and a Glimpse into the Future of Contrast-Enhanced MRI (Complete Session)

60:00Matthias Gutberlet, Leipzig / DE, Carlo Cosimo Quattrocchi, Trento / IT, Markus Berger, Berlin / DE, Sönke Peters, Kiel / DE

Description

Gadolinium-based contrast agents (GBCAs) have been used in over 800 million contrast-enhanced MRI (CE-MRI) applications worldwide in both patient diagnosis and follow-up scans. The unique in-vivo properties of GBCAs have enabled their widespread adoption, providing valuable diagnostic information across a broad range of indications and serving as an effective option for enhancing the MRI signal intensity.

We provide an important update for all those involved in CE-MRI. This session will focus on the latest innovations and ongoing developments in macrocyclic GBCAs. An expert multi-specialty panel will discuss the potential of optimized utilization of contrast agents in the context of international guidelines and patient preferences, setting the scene for the future of CE-MRI.

Gadoquatrane has not been approved in the European Union.


Learning Objectives:
• Understand the important role of GBCAs in MRI during diagnosis and patient follow up
• Explore latest innovations in GBCAs including an update of ongoing clinical development
• Discuss future directions in CE-MRI with the background of international imaging guidelines, environmental sustainability and patient preferences
PP-GD-ALL-0002-1 11.2024

10 min
GBCA use worldwide in clinical practice
Matthias Gutberlet, Leipzig / Germany
10 min
An intent to lower the gadolinium dose for CNS MR imaging in adults
Carlo Cosimo Quattrocchi, Trento / Italy
10 min
Discovery of Bayer’s low dose mGBCA
Markus Berger, Berlin / Germany
10 min
Phase 1 and 2 study results
Sönke Peters, Kiel / Germany
20 min
Panel discussion
Matthias Gutberlet, Leipzig / Germany

Comments

Type your comment here…

This commenting area is designed as a platform to ask questions related to the session content. If you have queries concerning the functionality of ESR Connect, please refer to the FAQs.

CME and Attendance Certificate

Only users with an ECR registration can claim CME credits and the Certificate of Attendance for Free Sessions.

This session offers AI-generated subtitles.

Speakers

  • Matthias Gutberlet

    Leipzig / Germany
  • Carlo Cosimo Quattrocchi

    Trento / Italy
  • Markus Berger

    Berlin / Germany
  • Sönke Peters

    Kiel / Germany